Jacqueline joined BI-Miami in 2012 as a trademark attorney with BI’s in-house legal team. In a position that allowed her […]
Cristina Milesi, Pharm.D.
Dr. Cristina Milesi joined BI – Miami in 2014 as a Drug Safety Evaluator. Prior to joining Brand Institute, she […]
José-Ángel Ferrero, PharmaD
Dr. Ferrero joined DSI – London in 2017 as Drug Safety Institute – Vice President, EU Regulatory Affairs & Safety […]
Sandra Van Laan
Ms. Van Laan joined DSI – Chicago in 2006 and is currently the President, Regulatory Affairs, Nonproprietary Division. Prior to […]
Nora Roselle, PharmD
Dr. Roselle joined DSI – Rockville as Managing Director of U.S. Regulatory Affairs in 2007, promoted in 2012 to Vice […]
Scott Sawler, JD, RPh
Mr. Sawler joined DSI – Ottawa as Managing Director, Canadian Regulatory Affairs in 2017 and in 2018 was promoted to […]
Ioannis (Nakos) Balamotis, PharmD
Dr. Balamotis joined DSI – London as Managing Director, EU Regulatory Affairs in 2014 and in 2018 was promoted to […]
Sophia Fuerst, MS, MBA
Ms. Fuerst joined Drug Safety Institute’s Nonproprietary (USAN/INN) Names Division as Managing Director in 2005, and was promoted to President […]
Todd Bridges, RPh
Mr. Bridges joined Drug Safety Institute (DSI) – Rockville, the Regulatory Affairs subsidiary of Brand Institute (BI) in May 2018 […]
Steve Anderson
Mr. Anderson joined BI – New York as Vice President, Trademarks & Head of Product in 2021. He is an […]